Ethambutol/isoniazid/rifampicin
| Combination of | |
|---|---|
| ethambutol | anti-tuberculosis medication |
| isoniazid | anti-tuberculosis medication |
| rifampicin | anti-tuberculosis medication |
| Clinical data | |
| ATC code | |
| Identifiers | |
| ChemSpider |
|
Ethambutol/isoniazid/rifampicin, also known as ethambutol/isoniazid/rifampin, is a medication used to treat tuberculosis. It is a fixed dose combination of ethambutol, isoniazid, and rifampicin. It is used either along or with other antituberculosis medication. It is taken by mouth.[1] Side effects are those of the underlying medications.[1] Use may not be suitable in children.[1]
It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.[2] The wholesale cost in the developing world is about 6.74 to 16.13 USD a month.[3]
See also
References
- 1 2 3 WHO Model Formulary 2008 (PDF). World Health Organization. 2009. p. 142. ISBN 9789241547659. Retrieved 8 December 2016.
- ↑ "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Retrieved 8 December 2016.
- ↑ "Rifampicin + Isoniazid + Ethambutol". International Drug Price Indicator Guide. Retrieved 8 December 2016.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.